COVID19

Heparin May Benefit Moderately Ill Patients With COVID-19

Moderately ill COVID-19 inpatients with increased D-dimer levels receiving therapeutic heparin compared with prophylactic heparin did not have a reduction in the primary outcome of death, mechanical ventilation, or intensive care unit admission at 28 days, but they did have decreased odds of death.

Next post in General Medicine